Fetal mouse Cyp1b1 and transplacental carcinogenesis from maternal exposure to dibenzo(a,l)pyrene

Cancer Prevention Research

Volumn 1, Issue 2, 2008, Pages 128-134

  Castro, David J ^a,b   Baird, William M ^a   Pereira, Clifford B ^a   Giovanini, Jack ^a   Löhr, Christiane V ^a   Fischer, Kay A ^a   Yu, Zhen ^b   Gonzalez, Frank J ^c   Krueger, Sharon K ^b   Williams, David E ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE DERIVATIVE; CARCINOGEN; CYP1B1 PROTEIN, MOUSE; DIBENZO(A,L)PYRENE; UNSPECIFIC MONOOXYGENASE;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; ENZYMOLOGY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FETUS MORTALITY; GENETICS; LUNG TUMOR; LYMPHOMA; METABOLISM; MORTALITY; MOUSE; NEOPLASM; PREGNANCY; THYMOMA; TRANSGENIC MOUSE;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BENZOPYRENES; CARCINOGENS; FEMALE; FETAL MORTALITY; FETUS; LUNG NEOPLASMS; LYMPHOMA; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS; PREGNANCY; THYMUS NEOPLASMS;

EID: 49649101404     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-07-0004     Document Type: Article

References (50)

1. Anderson LM. Introduction and overview. Perinatal carcinogenesis: growing a node for epidemiology, risk management, and animal studies. Toxicol Appl Pharmacol 2004;199:85-90.
2. Anderson LM. Predictive values of traditional animal bioassay studies for human perinatal carcinogenesis risk determination. Toxicol Appl Pharmacol 2004;199:162-74.
3. Shen J, Liu J, Xie Y, Diwan BA, Waalkes MP. Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. Toxicol Sci 2007;95:313-20.
4. Anderson LM, Hecht SS, Dixon DE, et al. Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone in mice. Cancer Res 1989;49:3770-5.
5. Walker DM, Malarkey DE, Seilkop SK, et al. Transplacental carcinogenicity of 3′-azido-3′-deoxythymidine in B6C3F1 mice and F344 rats. Environ Mol Mutagen 2007;48:283-98.
6. Hasegawa R, Kimura J, Yaono M, et al. Increased risk of mammary carcinoma development following transplacental and trans-breast milk exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in Sprague-Dawley rats. Cancer Res 1995;55:4333-8.
7. Miller MS. Transplacental lung carcinogenesis: molecular mechanisms and pathogenesis. Toxicol Appl Pharmacol 2004;198:95-110.
8. Yu Z, Loehr CV, Fischer KA, et al. In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor. Cancer Res 2006;66:755-62.
9. Yu Z, Mahadevan B, Lohr CV, et al. Indole-3-carbinol in the maternal diet provides chemoprotection for the fetus against transplacental carcinogenesis by the polycyclic aromatic hydrocarbon dibenzo[a,l] pyrene. Carcinogenesis 2006;27:2116-23.
10. Castro DJ, Yu Z, Löhr C, et al. Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine. Carcinogenesis 2008. In press.
11. Luch A, Coffing SL, Tang YM, et al. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene. Chem Res Toxicol 1998;11:686-95.
12. Shimada T, Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 2004;95:1-6.
13. Buters JT, Mahadevan B, Quintanilla-Martinez L, et al. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation. Chem Res Toxicol 2002;15:1127-35.
14. Luch A, Mahadevan B, Baird WM, et al. The role of cytochrome P450 1B1 in dibenzo[a,l]pyrene-induced carcinogenesis. Polycyclic Aromatic Hydrocarbons 2002;22:781-9.
15. Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, Stoilov I. Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 2003; 414:91-100.
16. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch Biochem Biophys 2005;436:50-61.
17. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model 2000. New York: Springer.
18. Xu M, Nelson GB, Moore JE, et al. Induction of Cyp1a1 and Cyp1b1 and formation of DNA adducts in C57BL/6, Balb/c, and F1 mice following in utero exposure to 3-methylcholanthrene. Toxicol Appl Pharmacol 2005;209:28-38.
19. Shimada T, Oda Y, Gillam EM, Guengerich FP, Inoue K. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab Dispos 2001;29: 1176-82.
20. Kleiner HE, Vulimiri SV, Hatten WB, et al. Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis. Chem Res Toxicol 2004;17:1667-74.
21. Lightfoot TJ, Roman E. Causes of childhood leukaemia and lymphoma. Toxicol Appl Pharmacol 2004;199:104-17.
22. Bunin GR. Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies. Toxicol Appl Pharmacol 2004;199:91-103.
23. Wild CP, Kleinjans J. Children and increased susceptibility to environmental carcinogens: evidence or empathy? Cancer Epidemiol Biomarkers Prev 2003;12:1389-94.
24. Alexander FE, Patheal SL, Biondi A, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 2001;61: 2542-6.
25. Ma X, Buffler PA, Gunier RB, et al. Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect 2002;110:955-60.
26. Perera F, Hemminki K, Jedrychowski W, et al. In utero DNA damage from environmental pollution is associated with somatic gene mutation in newborns. Cancer Epidemiol Biomarkers Prev 2002; 11:1134-7.
27. Reynolds P, Von Behren J, Gunier RB, Goldberg DE, Hertz A, Harnly ME. Childhood cancer and agricultural pesticide use: an ecologic study in California. Environ Health Perspect 2002;110:319-24.
28. Flower KB, Hoppin JA, Lynch CF, et al. Cancer risk and parental pesticide application in children of Agricultural Health Study participants. Environ Health Perspect 2004;112:631-5.
29. Kato I, Watanabe-Meserve H, Koenig KL, et al. Pesticide product use and risk of non-Hodgkin lymphoma in women. Environ Health Perspect 2004; 112:1275-81.
30. Quintana PJ, Delfino RJ, Korrick S, et al. Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma. Environ Health Perspect 2004;112: 854-61.
31. Shu XO, Perentesis JP, Wen W, et al. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev 2004; 13:1230-5.
32. De Roos AJ, Hartge P, Lubin JH, et al. Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res 2005;65: 11214-26.
33. Infante-Rivard C, Siemiatycki J, Lakhani R, Nadon L. Maternal exposure to occupational solvents and childhood leukemia. Environ Health Perspect 2005;113:787-92.
34. Anderson LM, Ruskie S, Carter J, Pittinger S, Kovatch RM, Riggs CW. Fetal mouse susceptibility to transplacental carcinogenesis: differential influence of Ah receptor phenotype on effects of 3-methylcholanthrene, 12-dimethylbenz[a]anthracene, and benzo [a]pyrene. Pharmacogenetics 1995;5:364-72.
35. Vesselinovitch SD, Koka M, Mihailovich N, Rao KV. Carcinogenicity of diethylnitrosamine in newborn, infant, and adult mice. J Cancer Res Clin Oncol 1984;108:60-5.
36. Vesselinovitch SD, Mihailovich N, Wogan GN, Lombard LS, Rao KV. Aflatoxin B1, a hepatocarcinogen in the infant mouse. Cancer Res 1972;32: 2289-91.
37. Rodriguez LV, Dunsford HA, Steinberg M, et al. Carcinogenicity of benzo[a]pyrene and manufactured gas plant residues in infant mice. Carcinogenesis 1987;18:127-35.
38. Stewart SL, King JB, Thompson TD, Friedman DO, Wingo PA. Cancer mortality surveillance-United States, 1990-2000. MMWR Surveill Summ 2006;53: 1-108.
39. Teitell MA, Pandolfi PP, Holland EC. Lymphoid malignancies. Mouse models of human cancer 2004. New York: John Wiley & Sons, Inc. p 237-59.
40. Morse HC, III, Anver MR, Fredrickson TN, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 2002;100:246-58.
41. Cavalieri EL, Rogan EG. Radical cations in aromatic hydrocarbon carcinogenesis. Free Radic Res Commun 1990;11:77-87.
42. Palackal NT, Burczynski ME, Harvey RG, Penning TM. The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carcinogen trans-dihydrodiols to o-quinones: potential role in polycyclic aromatic hydrocarbon activation. Biochemistry 2001;40: 10901-10.
43. Tokizane T, Shiina H, Igawa M, et al. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 2005;11:5793-801.
44. Nakajima M, Iwanari M, Yokoi T. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells. Toxicol Lett 2003;144:247-56.
45. Guengerich PF, Chun YJ, Kim D, Gilliam EM, Shimada T. Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat Res 2003;523-4:173-82.
46. Roos PH, Bolt HM. Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. Expert Opin Drug Metab Toxicol 2005;1: 187-202.
47. Shimada T, Watanabe J, Inoue K, Guengerich FP, Gilliam EM. Specificity of 17β-oestradiol and benzo (a)pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432. Xenobiotica 2001;31:163-76.
48. Shimada T, Watanabe J, Kawajiri K, et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 1999;20:1607-13.
49. Wenzlaff AS, Cote ML, Bock CH, et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005;26:2207-12.
50. Livingston RJ, Von Niederhausem A, Jegga AG, et al. Pattern of sequence variation across 213 environmental response genes. Genome Res 2004; 14:1821-31.